Purple Biotech (PPBT) Share-based Compensation (IS) (2017 - 2026)
Purple Biotech (PPBT) reported Share-based Compensation (IS) of $93000.0 for Q1 2026, little changed year-over-year from $93000.0 in Q1 2025, and little changed on a QoQ basis from $93000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Share-based Compensation (IS) data on file, last reported at $93000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.45 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 14.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | -240,000.00 |
| Dec 31, 2025 | -240,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | -344,000.00 |
| Dec 31, 2024 | -344,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | 449,000.00 |
| Sep 30, 2023 | 449,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 752,000.00 |
| Mar 31, 2023 | 752,000.00 |
| Dec 31, 2022 | 839,000.00 |
| Dec 31, 2022 | 839,000.00 |
| Sep 30, 2022 | 707,000.00 |
| Sep 30, 2022 | 707,000.00 |
| Jun 30, 2022 | 557,000.00 |
| Jun 30, 2022 | 557,000.00 |
| Mar 31, 2022 | 309,000.00 |
| Mar 31, 2022 | 309,000.00 |
| Dec 31, 2021 | 305,000.00 |
| Dec 31, 2021 | 305,000.00 |
| Sep 30, 2021 | 392,000.00 |
| Sep 30, 2021 | 392,000.00 |
| Jun 30, 2021 | 675,000.00 |
| Jun 30, 2021 | 675,000.00 |
| Mar 31, 2021 | 710,000.00 |
| Mar 31, 2021 | 710,000.00 |
| Dec 31, 2020 | 1.90 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Dec 31, 2019 | 773,000.00 |
| Dec 31, 2019 | 773,000.00 |
| Dec 31, 2018 | 161,000.00 |
| Dec 31, 2018 | 161,000.00 |
| Dec 31, 2017 | 1.03 Mn |
| Dec 31, 2017 | 1.03 Mn |